Basilea Pharmaceutica
Presença
Basilea Pharmaceutica é uma empresa listada sob o símbolo BPMUF (CH).
Executivos
Veja o organograma con seus 11 executivos principais
Biografias mais buscadas da Basilea Pharmaceutica
- David Veitch, Chief Executive Officer
- Martin Nicklasson, Member of the Board of Directors
- Domenico Scala, Chairman of the Board
Criar um alerta
para seguir os movimentos de executivos da Basilea Pharmaceutica.
Farmacêutica
Basilea Pharmaceutica possui 1.869 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
- Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Basilea Pharmaceutica
- https://www.basilea.com/news/news/basilea-announces-us-fda-approval-of-antibiotic-zevterar-ceftobiprole-medocaril-for-three-indications?type=1546938654
- https://www.basilea.com/news/news/continued-strong-cresembar-isavuconazole-sales-performance-in-asia-pacific-and-china-triggers-milestone-payment-to-basilea?type=1546938654
- https://www.basilea.com/news/news/basilea-reports-strong-2023-full-year-results-with-profitability-significantly-above-guidance-whilst-substantially-expanding-the-rd-portfolio?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-acquisition-of-preclinical-antibiotics-program-from-spexis?type=1546938654
- https://www.basilea.com/news/news/cresembar-sales-in-latin-america-trigger-first-sales-milestone-payment-to-basilea?type=1546938654
- https://www.basilea.com/news/news/basilea-provides-portfolio-status-update?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-accelerated-loan-repayment?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-that-fda-approves-expanded-use-of-antifungal-cresembar-isavuconazole-in-the-united-states-in-children-with-invasive-aspergillosis-and-invasive-mucormycosis?type=1546938654
- https://www.basilea.com/news/news/continued-strong-cresembar-isavuconazole-sales-performance-in-asia-pacific-and-china-triggers-third-sales-milestone-payment-for-the-region-from-pfizer-this-year?type=1546938654
- https://www.basilea.com/news/news/basilea-announces-exclusive-license-and-option-agreement-for-potential-first-in-class-clinical-stage-antibacterial-agent?type=1546938654
- View more press releases Close
Redes sociais sobre Basilea Pharmaceutica
- Basilea Pharmaceutica na Wikipedia, Google News e Yahoo Finance
- Basilea Pharmaceutica na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo David Veitch 
Ligue para a Basilea Pharmaceutica em +41 61...
